HomeInsightsResults

Aarti Pharmalabs Ltd Quarterly Result

Aarti Pharmalabs Ltd Quarterly Result

stocks purchased

₹ 1.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

27.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Net Profit

₹ 54.62

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Aarti Pharmalabs Ltd for the Sep '24 is ₹ 462.51 crore as compare to the Jun '24 revenue of ₹ 557.71 crore. This represent the decline of -17.069805%.
  • The ebitda of Aarti Pharmalabs Ltd for the Sep '24 is ₹ 98.16 crore as compare to the Jun '24 ebitda of ₹ 98.68 crore. This represent the decline of -0.5269524%.
  • The net profit of Aarti Pharmalabs Ltd for the Sep '24 is ₹ 54.62 crore as compare to the Jun '24 net profit of ₹ 55.45 crore. This represent the decline of -1.4968473%.

Results Analysis

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 2024617.8
19 Nov 2024634.55
18 Nov 2024640.5
14 Nov 2024656.35
13 Nov 2024648.15
12 Nov 2024654.2
11 Nov 2024634.2
08 Nov 2024659.25
07 Nov 2024687.85
06 Nov 2024677.65

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Aarti Pharmalabs Ltd News Hub

News

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the ...

Read more

28 Oct 202417:31

News

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 Octobe...

Read more

22 Oct 202410:37

News

Aarti Pharmalabs to convene board meeting

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 5 August ...

Read more

30 Jul 202411:17

News

Aarti Pharmalabs schedules AGM

Aarti Pharmalabs announced that the 91th Annual General Meeting (AGM) of the company will ...

Read more

17 Jul 202409:30

News

CRISIL reaffirms ratings of Aarti Pharmalabs with 'positive' outlook

CRISIL stated that the ratings continue to reflect the established market position in the ...

Read more

27 Jun 202413:54

News

Aarti Pharmalabs Ltd leads losers in 'A' group

Colgate-Palmolive (India) Ltd, Jyothy Labs Ltd, Archean Chemical Industries Ltd and Aarti ...

Read more

15 May 202415:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Aarti Pharmalabs Ltd Quarterly Result

What is the EPS of Aarti Pharmalabs Ltd stock?

The Earnings Per Share (EPS) of Aarti Pharmalabs Ltd is 25.17. An EPS is the amount of net income attributed to each share of a common stock.

How is Aarti Pharmalabs Ltd EPS calculated?

The EPS of Aarti Pharmalabs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aarti Pharmalabs Ltd report its EPS?

Aarti Pharmalabs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aarti Pharmalabs Ltd EPS?

Factors that influence the EPS of Aarti Pharmalabs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aarti Pharmalabs Ltd EPS growth indicate future performance?

Yes, consistent growth in Aarti Pharmalabs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*